Biofrontera (BFRIW)

• Market cap: $55.8K
• 1 day: -6.27%
• 5 days: -4.1%
• 1 month: -50%
• 3 months: -28.08%
• 6 months: -61.48%
• Year to date: -37.67%
• 1 year: -18.34%
• 5 years: -97.1%
• 10 years: -97.1%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.

Employees: 94